The Weekly Huddle

In the 68th session of the weekly huddle, we discuss optimal management strategy for patients presenting with acute MI (STEMI) at a peripheral center which doesn't have primary PCI capabilities.

In the 67th session, we discuss unique aspects of managing hypertension in young females of childbearing age. This topic overlaps a bit with managing hypertension in pregnancy and is directly relevant in cardiologists, internists, obstetricians among others.

As a cardiologist or a general physician, we are often called-in to give medical fitness for certain professions. The stakes are higher when it involves high risk professions like pilot. In this 66th session, we discuss issues pertaining to the same.

In this 65th session, we had quite an interactive discussion with Dr. P C Gupta (vascular surgeon) where he shared tips and tricks of managing varicose veins.

How many of you advise your patients to go for self monitored blood pressure at home? Is SMBP a key tool for hypertension management or adds more confusion? We discuss this today in our 64th session.

How many of you advise your patients to go for self monitored blood pressure at home? Is SMBP a key tool for hypertension management or adds more confusion? We discuss this today in our 64th session.

A common scenario is when we get lots of PVCs on the treadmill test (TMT) and there is no consensus as to what does it signify. In our 63rd session, I take my colleagues' opinion on how do they interpret this finding and further management.

We discuss a case of a patient who is on high dose statin, now complaints of with hematuria and thigh pain.

Antibody-drug cocktail for COVID was recently approved for commercial use in India. We discuss the practical aspects of using this drug in clinical practice. To facilitate the discussion, we invited the index clinical case himself to guide us with his experience. Heartfelt thanks to Dr. Vishwakranth (an eminent cardiologist at Hyderabad) who joined us to share his experience using this drug on himself.

In this 60th session, we discuss the optimal duration of dual antiplatelet therapy, in relation to post angioplasty patients who need surgery.